NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
551 Örebro |
Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
Benign sample | 100 | 3.0% | 33 | 1.0% | 5 | 0.1% | 1 | 0.0% | . | . | 15 | 0.4% | 3190 | 95.4% | 3344 | 100.0% |
ASCUS | 241 | 22.8% | 174 | 16.5% | 55 | 5.2% | 4 | 0.4% | . | . | 69 | 6.5% | 514 | 48.6% | 1057 | 100.0% |
LSIL | 151 | 15.9% | 206 | 21.6% | 140 | 14.7% | 1 | 0.1% | . | . | 56 | 5.9% | 398 | 41.8% | 952 | 100.0% |
Atypical glandular cells/AGC | 5 | 18.5% | 1 | 3.7% | 1 | 3.7% | 7 | 25.9% | 2 | 7.4% | . | . | 11 | 40.7% | 27 | 100.0% |
Unclear atypia | 15 | 30.6% | 5 | 10.2% | 12 | 24.5% | 2 | 4.1% | 1 | 2.0% | 3 | 6.1% | 11 | 22.4% | 49 | 100.0% |
ASC-H | 2 | 28.6% | . | . | 5 | 71.4% | . | . | . | . | . | . | . | . | 7 | 100.0% |
HSIL | 13 | 4.6% | 24 | 8.5% | 214 | 75.6% | 5 | 1.8% | 4 | 1.4% | 10 | 3.5% | 13 | 4.6% | 283 | 100.0% |
Suspected Adenocarcinom | . | . | . | . | . | . | . | . | . | . | . | . | 4 | 100.0% | 4 | 100.0% |
Malignant tumor with unclear origin | . | . | . | . | . | . | . | . | . | . | . | . | 2 | 100.0% | 2 | 100.0% |
Squamous cell cancer | . | . | . | . | 1 | 50.0% | . | . | . | . | . | . | 1 | 50.0% | 2 | 100.0% |
Totalt | 527 | 9.2% | 443 | 7.7% | 433 | 7.6% | 20 | 0.3% | 7 | 0.1% | 153 | 2.7% | 4144 | 72.4% | 5727 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81403 |